Cargando…

An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools

BACKGROUND: Fibromyalgia (FM) is a chronic, debilitating pain disorder. Dissatisfaction with conventional medicine can lead people with FM to turn to complementary and alternative medicine (CAM). Two previous overviews of systematic reviews of CAM for FM have been published, but they did not assesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Perry, Rachel, Leach, Verity, Davies, Philippa, Penfold, Chris, Ness, Andy, Churchill, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433031/
https://www.ncbi.nlm.nih.gov/pubmed/28506257
http://dx.doi.org/10.1186/s13643-017-0487-6
_version_ 1783236763537375232
author Perry, Rachel
Leach, Verity
Davies, Philippa
Penfold, Chris
Ness, Andy
Churchill, Rachel
author_facet Perry, Rachel
Leach, Verity
Davies, Philippa
Penfold, Chris
Ness, Andy
Churchill, Rachel
author_sort Perry, Rachel
collection PubMed
description BACKGROUND: Fibromyalgia (FM) is a chronic, debilitating pain disorder. Dissatisfaction with conventional medicine can lead people with FM to turn to complementary and alternative medicine (CAM). Two previous overviews of systematic reviews of CAM for FM have been published, but they did not assessed for risk of bias in the review process. METHODS: Five databases Medline, Embase, AMED (via OVID), Web of Science and Central were searched from their inception to December 2015. Reference lists were hand-searched. We had two aims: the first was to provide an up-to-date and rigorously conducted synthesis of systematic reviews of CAM literature on FM; the second was to evaluate the quality of the available systematic review evidence using two different tools: AMSTAR (Shea et al. BMC Med Res Methodol 15; 7:10, 2007) and a more recently developed tool ROBIS (Whiting et al. J Clin Epidemiol 69:225-34, 2016) specifically designed to assess risk of bias in systematic reviews. Any review that assessed one of eight CAM therapies for participants diagnosed with FM was considered. The individual studies had to be randomised controlled trials where the intervention was compared to placebo, treatment as usual or waitlist controls to be included. The primary outcome measure was pain, and the secondary outcome measure was adverse events. RESULTS: We identified 15 reviews that met inclusion criteria. There was low-quality evidence that acupuncture improves pain compared to no treatment or standard treatment, but good evidence that it is no better than sham acupuncture. The evidence for homoeopathy, spinal manipulation and herbal medicine was limited. CONCLUSIONS: Overall, five reviews scored 6 or above using the AMSTAR scale and the inter-rater agreement was good (83.6%), whereas seven reviews achieved a low risk of bias rating using ROBIS and the inter-rater agreement was fair (60.0%). No firm conclusions were drawn for efficacy of either spinal manipulation or homoeopathy for FM. There is limited evidence for topical Capsicum, but further research is required. There is some evidence to support the effectiveness of acupuncture for FM, but further high-quality trials are needed to investigate its benefits, harms and mechanisms of action, compared with no or standard treatment. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016035846.
format Online
Article
Text
id pubmed-5433031
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54330312017-05-17 An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools Perry, Rachel Leach, Verity Davies, Philippa Penfold, Chris Ness, Andy Churchill, Rachel Syst Rev Research BACKGROUND: Fibromyalgia (FM) is a chronic, debilitating pain disorder. Dissatisfaction with conventional medicine can lead people with FM to turn to complementary and alternative medicine (CAM). Two previous overviews of systematic reviews of CAM for FM have been published, but they did not assessed for risk of bias in the review process. METHODS: Five databases Medline, Embase, AMED (via OVID), Web of Science and Central were searched from their inception to December 2015. Reference lists were hand-searched. We had two aims: the first was to provide an up-to-date and rigorously conducted synthesis of systematic reviews of CAM literature on FM; the second was to evaluate the quality of the available systematic review evidence using two different tools: AMSTAR (Shea et al. BMC Med Res Methodol 15; 7:10, 2007) and a more recently developed tool ROBIS (Whiting et al. J Clin Epidemiol 69:225-34, 2016) specifically designed to assess risk of bias in systematic reviews. Any review that assessed one of eight CAM therapies for participants diagnosed with FM was considered. The individual studies had to be randomised controlled trials where the intervention was compared to placebo, treatment as usual or waitlist controls to be included. The primary outcome measure was pain, and the secondary outcome measure was adverse events. RESULTS: We identified 15 reviews that met inclusion criteria. There was low-quality evidence that acupuncture improves pain compared to no treatment or standard treatment, but good evidence that it is no better than sham acupuncture. The evidence for homoeopathy, spinal manipulation and herbal medicine was limited. CONCLUSIONS: Overall, five reviews scored 6 or above using the AMSTAR scale and the inter-rater agreement was good (83.6%), whereas seven reviews achieved a low risk of bias rating using ROBIS and the inter-rater agreement was fair (60.0%). No firm conclusions were drawn for efficacy of either spinal manipulation or homoeopathy for FM. There is limited evidence for topical Capsicum, but further research is required. There is some evidence to support the effectiveness of acupuncture for FM, but further high-quality trials are needed to investigate its benefits, harms and mechanisms of action, compared with no or standard treatment. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016035846. BioMed Central 2017-05-15 /pmc/articles/PMC5433031/ /pubmed/28506257 http://dx.doi.org/10.1186/s13643-017-0487-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Perry, Rachel
Leach, Verity
Davies, Philippa
Penfold, Chris
Ness, Andy
Churchill, Rachel
An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools
title An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools
title_full An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools
title_fullStr An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools
title_full_unstemmed An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools
title_short An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools
title_sort overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both amstar and robis as quality assessment tools
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433031/
https://www.ncbi.nlm.nih.gov/pubmed/28506257
http://dx.doi.org/10.1186/s13643-017-0487-6
work_keys_str_mv AT perryrachel anoverviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT leachverity anoverviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT daviesphilippa anoverviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT penfoldchris anoverviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT nessandy anoverviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT churchillrachel anoverviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT perryrachel overviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT leachverity overviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT daviesphilippa overviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT penfoldchris overviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT nessandy overviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools
AT churchillrachel overviewofsystematicreviewsofcomplementaryandalternativetherapiesforfibromyalgiausingbothamstarandrobisasqualityassessmenttools